KYTX LAWSUIT ALERT: Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / February 5, 2025 / If you suffered a loss on your Kyverna Therapeutics, Inc. (NASDAQ:KYTX) investment and want ...
Hosted on MSN17d
Kyverna Therapeutics appoints new chief medical officer
Kyverna's CEO Warner Biddle expressed confidence in Dr. Gehchan's ability to lead the company through its next growth phase, particularly as it advances its lead CAR T-cell therapy candidate, KYV ...